119 related articles for article (PubMed ID: 18335226)
1. Comparison of multiple dose GnRH antagonist and minidose long agonist protocols in poor responders undergoing in vitro fertilization: a randomized controlled trial.
Tazegül A; Görkemli H; Ozdemir S; Aktan TM
Arch Gynecol Obstet; 2008 Nov; 278(5):467-72. PubMed ID: 18335226
[TBL] [Abstract][Full Text] [Related]
2. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization.
Barmat LI; Chantilis SJ; Hurst BS; Dickey RP
Fertil Steril; 2005 Feb; 83(2):321-30. PubMed ID: 15705369
[TBL] [Abstract][Full Text] [Related]
3. Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs.
Orvieto R; Kruchkovich J; Rabinson J; Zohav E; Anteby EY; Meltcer S
Fertil Steril; 2008 Jul; 90(1):228-30. PubMed ID: 17681292
[TBL] [Abstract][Full Text] [Related]
4. Low-dose GnRH antagonist protocol is as effective as the long GnRH agonist protocol in unselected patients undergoing in vitro fertilization and embryo transfer.
Huang SY; Huang HY; Yu HT; Wang HS; Chen CK; Lee CL; Soong YK
Taiwan J Obstet Gynecol; 2011 Dec; 50(4):432-5. PubMed ID: 22212313
[TBL] [Abstract][Full Text] [Related]
5. Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI.
Mohsen IA; El Din RE
Gynecol Endocrinol; 2013 Feb; 29(2):105-8. PubMed ID: 23134528
[TBL] [Abstract][Full Text] [Related]
6. Comparisons of different dosages of gonadotropin-releasing hormone (GnRH) antagonist, short-acting form and single, half-dose, long-acting form of GnRH agonist during controlled ovarian hyperstimulation and in vitro fertilization.
Hsieh YY; Chang CC; Tsai HD
Taiwan J Obstet Gynecol; 2008 Mar; 47(1):66-74. PubMed ID: 18400585
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of GnRH agonists and antagonists in an ovular donation program].
Saucedo de la Llata E; Moraga Sánchez MR; Batiza Reséndiz V; Santos Haliscak R; Galache Vega P; Hernández Ayup S
Ginecol Obstet Mex; 2004 Feb; 72():53-6. PubMed ID: 15216901
[TBL] [Abstract][Full Text] [Related]
8. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of microdose leuprolide acetate protocol versus luteal phase ganirelix protocol in predicted poor responders.
DiLuigi AJ; Engmann L; Schmidt DW; Benadiva CA; Nulsen JC
Fertil Steril; 2011 Jun; 95(8):2531-3. PubMed ID: 21324455
[TBL] [Abstract][Full Text] [Related]
10. Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients.
Tehraninejad ES; Nasiri R; Rashidi B; Haghollahi F; Ataie M
Arch Gynecol Obstet; 2010 Sep; 282(3):319-25. PubMed ID: 20379731
[TBL] [Abstract][Full Text] [Related]
11. Delayed Start Versus Conventional GnRH Antagonist Protocol in Poor Responders Pretreated With Estradiol in Luteal Phase: A Randomized Controlled Trial.
Maged AM; Nada AM; Abohamila F; Hashem AT; Mostafa WA; Elzayat AR
Reprod Sci; 2015 Dec; 22(12):1627-31. PubMed ID: 26045549
[TBL] [Abstract][Full Text] [Related]
12. GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial.
Cheung LP; Lam PM; Lok IH; Chiu TT; Yeung SY; Tjer CC; Haines CJ
Hum Reprod; 2005 Mar; 20(3):616-21. PubMed ID: 15608037
[TBL] [Abstract][Full Text] [Related]
13. Controlled ovarian hyperstimulation using multi-dose gonadotropin-releasing hormone (GnRH) antagonist results in less systemic inflammation than the GnRH-agonist long protocol.
Orvieto R; Volodarsky M; Hod E; Homburg R; Rabinson J; Zohav E; Anteby EY; Meltcer S
Gynecol Endocrinol; 2007; 23(8):494-6. PubMed ID: 17852411
[TBL] [Abstract][Full Text] [Related]
14. The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study.
Engmann L; DiLuigi A; Schmidt D; Benadiva C; Maier D; Nulsen J
Fertil Steril; 2008 Mar; 89(3):554-61. PubMed ID: 17678651
[TBL] [Abstract][Full Text] [Related]
15. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?
Schoolcraft WB; Surrey ES; Minjarez DA; Stevens JM; Gardner DK
Fertil Steril; 2008 Jan; 89(1):151-6. PubMed ID: 17482177
[TBL] [Abstract][Full Text] [Related]
16. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
[TBL] [Abstract][Full Text] [Related]
17. In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols.
Farhi J; Ben-Haroush A; Lande Y; Sapir O; Pinkas H; Fisch B
Fertil Steril; 2009 Feb; 91(2):377-82. PubMed ID: 18321490
[TBL] [Abstract][Full Text] [Related]
18. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
[TBL] [Abstract][Full Text] [Related]
19. Menstrual cycle synchronization, ovarian stimulation, and in vitro fertilization in olive baboons (Papio anubis): a prospective randomized study.
Nyachieo A; Spiessens C; Chai DC; Mwenda JM; D'Hooghe TM
Fertil Steril; 2009 Feb; 91(2):602-10. PubMed ID: 18328482
[TBL] [Abstract][Full Text] [Related]
20. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
Engmann L; DiLuigi A; Schmidt D; Nulsen J; Maier D; Benadiva C
Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
